Zhen‐Bin Ding
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Hepatology 45
- Hepatocellular Carcinoma Treatment and Prognosis 42
- Liver physiology and pathology 4
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Jia Fan (75 shared papers)Ying–Hong Shi (48 shared papers)Jian Zhou (48 shared papers)Ai‐Wu Ke (25 shared papers)Shuang–Jian Qiu (20 shared papers)Xiaoying Wang (19 shared papers)Guo‐Ming Shi (16 shared papers)Yuan‐Fei Peng (28 shared papers)
- Journals
- Hepatology (7 papers)BMC Cancer (4 papers)PLoS ONE (4 papers)Frontiers in Oncology (3 papers)Cancer (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhen‐Bin Ding
101 papers receiving 5.3k citations
Zhen‐Bin Ding's Hit Papers
Peers
Comparison fields: 5 of 94
- Hepatology 1.2k
- Cancer Research 717
- Oncology 1k
- Immunology and Allergy 177
- Epidemiology 797
Countries citing papers authored by Zhen‐Bin Ding
This map shows the geographic impact of Zhen‐Bin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen‐Bin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen‐Bin Ding more than expected).
Fields of papers citing papers by Zhen‐Bin Ding
This network shows the impact of papers produced by Zhen‐Bin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen‐Bin Ding. The network helps show where Zhen‐Bin Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhen‐Bin Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor Hit paper breakdown → | 2023 | 275 |
| 2 | 2008 | 247 | |
| 3 | 2013 | 247 | |
| 4 | 2013 | 200 | |
| 5 | 2008 | 196 | |
| 6 | 2014 | 196 | |
| 7 | 2011 | 164 | |
| 8 | 2011 | 159 | |
| 9 | 2012 | 150 | |
| 10 | 2013 | 148 | |
| 11 | 2020 | 143 | |
| 12 | 2008 | 139 | |
| 13 | 2022 | 133 | |
| 14 | 2011 | 126 | |
| 15 | 2018 | 120 | |
| 16 | 2018 | 119 | |
| 17 | 2010 | 116 | |
| 18 | 2014 | 108 | |
| 19 | 2014 | 105 | |
| 20 | 2015 | 101 |
About Zhen‐Bin Ding
Zhen‐Bin Ding is a scholar working on Hepatology, Cancer Research, Surgery, Oncology and Epidemiology, having authored 105 papers that have together received 5.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (42 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers), Autophagy in Disease and Therapy (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune cells in cancer (5 papers), Cancer Genomics and Diagnostics (5 papers), Liver physiology and pathology (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (717 citations), Oncology (1k citations), Immunology and Allergy (177 citations) and Epidemiology (797 citations). Zhen‐Bin Ding has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jia Fan, Ying–Hong Shi, Jian Zhou, Ai‐Wu Ke, Shuang–Jian Qiu, Xiaoying Wang, Guo‐Ming Shi, Yuan‐Fei Peng, Zhi Dai and Qiang Gao. Their work appears in journals such as Hepatology, BMC Cancer, PLoS ONE, Frontiers in Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.